Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Suvorexant for Insomnia and Craving in Substance Use Disorder
NCT03412591Phase 3Completed
- Sponsor
- Penn State Health Milton S. Hershey Medical Center
- Start
- Jul 2019
- Primary completion
- Jan 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of suvorexant in Insomnia, alcohol use disorder (AUD), opioid use disorder (OUD), sponsored by Penn State Health Milton S. Hershey Medical Center. Started Jul 2019; status: completed.
02
Drugs
suvorexant
03
Conditions
Insomniaalcohol use disorder (AUD)opioid use disorder (OUD)
Beyond the preview
Go deeper on NCT03412591.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03412591.